HOME >> BIOLOGY >> NEWS
Completion of the Drosophila genome sequence

The Drosophila research community thanks Celera Genomics and the publicly-funded genome projects for delivering the fruitfly genome sequence

PITTSBURGH, PENN. March 23, 2000 -- The publication and release of the complete DNA sequence of the fruit fly Drosophila in the current issue of Science reports an achievement that will have enormous impact on understanding human biology and disease. Nearly two-thirds of the genes known to cause human disease are present in the Drosophila genome, including genes responsible for birth defects, neurodegeneration, and cancer. These findings demonstrate that basic research using Drosophila has enormous value in the fight against human disease.

This occasion caps a century of ground-breaking discoveries made using Drosophila, several of which were recognized by Nobel prizes. These include the demonstration that radiation causes mutations and the discovery of genes that control the basic body plan of all organisms.

Drosophila has the largest genome sequence produced to date. This daunting project was only accomplished at an accelerated pace because private industry and government funded public efforts collaborated in a true partnership. The Drosophila Board, representing the community of Drosophila researchers, sincerely thanks Celera Genomics, Inc. and the Drosophila Genome Projects for providing this important resource to our research community.

The completion of the Drosophila genome sequence heralds a new era of biomedical discovery. The Drosophila community welcomes this leap forward and the opportunity it affords to advance our understanding of how organisms function and how genetic defects cause disease.

The Drosophila Genome Project is a consortium of the Berkeley Genome Project, European Genome Project, Baylor College of Medicine Human Genome Center, and FlyBase. The Dros
'"/>

Contact: Gary Karpen
karpen@salk.edu
412-281-3700 ext2606
Salk Institute
22-Mar-2000


Page: 1 2

Related biology news :

1. A room with a view for the International Space Station: Completion of the cupola observation module
2. Completion of comprehensive index of human proteins to be presented at New York Academy Of Sciences
3. Drosophila genome sequence completed
4. Scientists sequence genome of kind of organism central to biospheres carbon cycle
5. Keep genome data freely accessible
6. The book opens on the first tree genome
7. NSF awards 22 new projects for plant genome research
8. Milk genome symposium
9. Environmental decontamination, greenhouse gases, and the genome of a methane-loving bacterium
10. Scientists explore genome of methane-breathing microbe
11. National Academies advisory: genome data and bioterrorism

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Completion the genome sequence

(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/12/2015)... Va. , March 12, 2015 IriTech, ... and a member of the Texas Instruments Design Network, ... Naidu has demonstrated its IriShield USB MK2120U device ... scanning facility for pension distribution. The ... assembled to be marketed in India ...
(Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
(Date:3/29/2015)... Texas , March 29, 2015 /PRNewswire/ ... presentation of important study data showing the ... in 1,599 gynecologic cancer samples. Using Caris ... profiling service, researchers identified expression of programmed ... cancers independent of histology while its ligand ...
(Date:3/27/2015)... 2015  Neogen Corporation (NASDAQ: NEOG ) announced ... trading plan in accordance with Securities and Exchange Commission ... of Neogen Corporation, is a minority owner of this ... Herbert does not have control of this ... is only for a portion of the shares owned ...
(Date:3/27/2015)... ROCKVILLE, Md. , March 27, 2015  CASI ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a commercial focus on ... the three and 12 months ended December 31, 2014.  ... of ($1.6 million), or ($0.05) per share, for the ...
(Date:3/26/2015)... The Market Element LLC, a leading inbound ... Designing Gig LLC to provide website design, development, and ... this alliance with Designing Gig represents a pivotal moment ... comprehensive, end-to-end, digital solution for our clients, which now ... Miller, president of The Market Element. “For small and ...
Breaking Biology Technology:Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2
Cached News: